Gene therapy for the treatment of chronic peripheral nervous system pain.
about
Changing channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitabilityGene delivery to the spinal cord using MRI-guided focused ultrasoundAAV-Mediated Gene Transfer to Dorsal Root Ganglion.Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.Current gene therapy using viral vectors for chronic painMethods for gene transfer to the central nervous system.Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice.Mechanisms of PDGF siRNA-mediated inhibition of bone cancer pain in the spinal cord.Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing EndonucleaseNew and developing drugs for the treatment of neuropathic pain in diabetes.Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations: A Comprehensive Review.Establishment of a novel therapeutic vector targeting the trigeminal ganglion in rats.Equine performance genes and the future of doping in horseracing.Replication-defective HSV-1 effectively targets trigeminal ganglion and inhibits viral pathopoiesis by mediating interferon gamma expression in SH-SY5Y cells.Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain.Origins and Neurochemical Characteristics of Porcine Intervertebral Disc Sympathetic Innervation: a Preliminary ReportThe K(+) channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia.The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.Gene therapy for neuropathic pain induced by spared nerve injury with naked plasmid encoding hepatocyte growth factor.Post-herpetic neuralgia - a review of current management and future directions.
P2860
Q28081164-61654458-A1E2-40E0-8818-62F7F694B8BDQ30394722-01772ADD-F567-4F4C-BE08-C22BCE6CF618Q33764228-71D9AA11-9A7B-48CA-9A44-DCE378CDD2A3Q34385062-C2422737-3F1B-42E4-99BB-3416092B94FCQ35658521-440746A3-0CDC-4113-A531-120506DD1A1AQ35902332-06BF0138-DFB1-4736-B97C-3CE1CE7119BAQ36921432-6F3A6A46-CBB4-4A35-B12F-25B94695FB9DQ36990758-F0EF03E7-D8AD-44B9-95EF-A5067677FC20Q37491434-148AE77A-BB9B-41DC-8D8C-A7C86CC3C911Q37634060-3869DB20-762B-47FE-8BC9-D8B9634FE222Q38114817-ECBDE4E5-B576-40B1-A15E-340E66799280Q38263540-F998693E-599E-482B-B346-24CC5258CE76Q38286636-5B8516A9-43B1-4E93-9FCE-4C790D490D83Q38738678-DAA2531C-ABB9-42DB-B061-BD7F9BBFE945Q39042425-65D251E1-8429-4037-AB40-CB578115283DQ40378943-7EA2A4AB-01DD-4E97-959A-15B0A77CB3F7Q41597212-73749B13-60E4-4A56-8A01-05AF8D305005Q41923805-DEEEAB64-D164-4C50-988B-F25E0FFA1B4FQ43749965-DC5DC5EB-4265-46D7-B3FB-342F0A44CFACQ45873482-4C1D496A-50C7-4A91-8914-B36E39EB0619Q47242634-8A8701BF-16EA-4CA6-B08F-15FD6D2E1F84
P2860
Gene therapy for the treatment of chronic peripheral nervous system pain.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gene therapy for the treatment of chronic peripheral nervous system pain.
@en
type
label
Gene therapy for the treatment of chronic peripheral nervous system pain.
@en
prefLabel
Gene therapy for the treatment of chronic peripheral nervous system pain.
@en
P2860
P1476
Gene therapy for the treatment of chronic peripheral nervous system pain.
@en
P2093
Joseph C Glorioso
William F Goins
P2860
P304
P356
10.1016/J.NBD.2012.05.005
P577
2012-06-02T00:00:00Z